The vaccine data link in Nha Trang, Vietnam: A progress report on the implementation of a database to detect adverse events related to vaccinations

Vaccine

Volumn 21, Issue 15, 2003, Pages 1681-1686

  Ali, Mohammad ^a   Canh, Do Gia ^b   Clemens, John D ^a   Park, Jin Kyung ^a   Von Seidlein, Lorenz ^a   Thiem, Vu Dinh ^b   Tho, Le Huu ^c   Trach, Dang Duc ^b  

^a International Vaccine Institute   (South Korea)

^b National Institute of Hygiene and Epidemiology   (Viet Nam)

^c Provincial Health Services   (Viet Nam)

Author keywords

Adverse events; Data link; Safety; Vaccines; Vietnam

Indexed keywords

VACCINE;

ARTICLE; COMPUTER PROGRAM; DATA BASE; DEVELOPING COUNTRY; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; RURAL AREA; SIDE EFFECT; VACCINATION; VIET NAM;

DATABASE MANAGEMENT SYSTEMS; DATABASES, FACTUAL; HUMANS; PROGRAM DEVELOPMENT; VACCINATION; VIETNAM;

EID: 0037413964     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00633-3     Document Type: Article

References (28)

1. England S, Loevinson B, Melgaard B, Kou U, Jha P, The evidence base for interventions to reduce mortality from vaccine-preventable diseases in low and middle-income countries. Commission on Macroeconomics and Health, Geneva, 2001.
2. Keja K., Chan C., Hayden G., Henderson R.H. Expanded programme on immunization. World Health Stat. Q. 41(2):1988;59-63.
3. Streefland P.H. Public doubts about vaccination safety and resistance against vaccination. Health Pol. 55(3):2001;159-172.
4. Nathanson N, Langmuir A. The cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination the United States during the spring of 1955. Part II. Relationship of poliomyelitis to cutter vaccine. Am. J. Hyg. 1963;78:61.
5. Whittle H., Hanlon P., O'Neill K.et al. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet. 2(8615):1988;811-814.
6. Aaby P., Jensen T.G., Hansen H.L.et al. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet. 2(8615):1988;809-811.
7. Aaby P., Samb B., Simondon F.et al. Child mortality after high-titre measles vaccines in Senegal: the complete data set. Lancet. 338(8781):1991;1518-1519.
8. Holt E.A., Moulton L.H., Siberry G.K., Halsey N.A. Differential mortality by measles vaccine titer and sex. J. Infect. Dis. 168(5):1993;1087-1096.
9. Halsey N.A. Increased mortality after high titer measles vaccines: too much of a good thing. Pediatr. Infect. Dis. J. 12(6):1993;462-465.
10. Anonymous. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999;48(43):1007.
11. Murphy T.V., Gargiullo P.M., Massoudi M.S.et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344(8):2001;564-572.
12. Wakefield A.J., Murch S.H., Anthony A.et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 351(9103):1998;637-641.
13. Stratton K, Gable A, Shelly P, McCormick M, Immunization safety review. Measles-mumps-rubella vaccine and autism. National Academy Press, Washington, DC, 2001.
14. Halsey, NA, Hyman, SL. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, 12-13 June 2000. Pediatrics 2001;107(5):E84.
15. Taylor B., Miller E., Farrington C.P.et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 353(9169):1999;2026-2029.
16. Taylor B., Miller E., Lingam R., Andrews N., Simmons A., Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 324(7334):2002;393-396.
17. Kristensen I., Aaby P., Jensen H. Routine vaccinations and child survival: follow-up study in Guinea-Bissau, West Africa. BMJ (Clin. Res. Ed.). 321(7274):2000;1435-1438.
18. Fine P. Commentary: an unexpected finding that needs confirmation or rejection. BMJ (Clin. Res. Ed.). 321(7274):2000;1439.
19. Chen R.T., Glasser J.W., Rhodes P.H.et al. Vaccine safety data link project: a new tool for improving vaccine safety monitoring in the United States. The vaccine safety data link team. Pediatrics. 99(6):1997;765-773.
20. DeStefano F. The vaccine safety data link project. Pharmacoepidemiol. Drug Saf. 10(5):2001;403-406.
21. Davis R.L., Kramarz P., Bohlke K.et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the vaccine safety data link project. Arch. Pediatr. Adolesc. Med. 155(3):2001;354-359.
22. Ray P., Black S., Shinefield H.et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine safety data link team. JAMA. 278(7):1997;551-556.
23. Kramarz P., DeStefano F., Gargiullo P.M.et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine safety data link team. Arch. Fam. Med. 9(7):2000;617-623.
24. DeStefano F., Mullooly J.P., Okoro C.A.et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 108(6):2001;E112.
25. Barlow W.E., Davis R.L., Glasser J.W.et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England J. Med. 345(9):2001;656-661.
26. Nguyen V.M., Nguyen V.T., Huynh P.L.et al. The epidemiology and disease burden of rotavirus in Vietnam: sentinel surveillance at six hospitals. J. Infect. Dis. 183(12):2001;1707-1712.
27. Canh D.G., Do T. General and diarrhea related mortality rates in Vietnamese children. J. Preventive Med. Vietnam. 3:1993;38.
28. Naficy A.B., Trach D.D., Ke N.T.et al. Cost of immunization with a locally produced, oral cholera vaccine in Vietnam. Vaccine. 19(27):2001;3720-3725.